Spontaneous Bacterial Peritonitis (SBP)
Overview
SBP is a serious infection of ascitic fluid, most commonly seen
in children with chronic liver disease. It occurs without an
evident intra-abdominal source and requires prompt diagnosis
and treatment.
Risk Factors
- Chronic liver disease (especially cirrhosis)
- Nephrotic syndrome
- Protein-losing enteropathy
- Congestive heart failure
- Acute liver failure or viral hepatitis
Pathophysiology
Children with ascites are immunocompromised due to low
complement levels, impaired neutrophil function, and increased
intestinal permeability, which facilitates bacterial
translocation.
Diagnosis
- Clinical signs: fever, abdominal pain, vomiting,
encephalopathy, renal dysfunction (may be subtle or may have
worsening fatigue)
- Paracentesis: PMN count ≥250 cells/mm³ is diagnostic
- Ascitic fluid analysis: low protein, low glucose, positive
culture (may be negative in 50%)
Common Pathogens
- Gram-negative: E. coli, Klebsiella pneumoniae
- Gram-positive: Streptococcus pneumoniae,
Enterococcus, Staphylococcus aureus
- Anaerobes are rare
Treatment
- Empiric antibiotics: Cefotaxime or
ceftriaxone
- Albumin therapy: 1.5 g/kg at diagnosis, 1
g/kg at 48 hours
- Supportive care: fluid restriction, nutritional support,
monitor renal function
Prophylaxis
- Secondary: Rifaximin, Bactrim, ciprofloxacin
- Primary: For high-risk patients (e.g.,
ascitic protein <1.5 g/dL)
Summary Table
| Aspect |
Details |
| Diagnosis |
PMN ≥250/mm³ in ascitic fluid |
| Common pathogens |
E. coli, Klebsiella, Strep pneumo, Enterococcus |
| Empiric antibiotics |
Cefotaxime or ceftriaxone |
| Albumin therapy |
1.5 g/kg at diagnosis, 1 g/kg at 48h |
| Culture yield |
Up to 50% may be negative |
| Prophylaxis options |
Rifaximin, Bactrim, ciprofloxacin |